We strongly encourage your contribution to our journal.
We are looking forward to receiving excellent and informative manuscripts.

Hirohisa Saito, Editor-in-Chief

All articles submitted to the journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor or the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.

All manuscripts are to be submitted and reviewed electronically using the Manuscript Central (MC) system at http://mc.manuscriptcentral.com/ai-jsa.

<Prohibition of double publication> Papers are accepted for publication in the journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter. The authors must be cautious even for review articles. Each reproduction must be accompanied by the citation.
<Ethical review for human study> Authors must also state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken. Experiments involving either human subjects or material of human origin should be carried out in accordance with the principles embodied in the Declaration of Helsinki of 1995 (as revised in Seoul 2008). All investigations on human subjects must include a statement that the subject gave a written informed consent and patient anonymity were preserved using documents and methods approved by the ethical review committee of the hospital. This statement must be given also in the text, Methods or elsewhere.
<Preregistration for clinical trials> Clinical trials such as pharmacological interventions should be preregistered to a public registry approved by WHO, for example, www.clinicaltrials.gov, or www.umin.ac.jp/ctr/index-j.htm. The disclosed information should include primary outcomes in order to prohibit post hoc analysis based on researchers' prejudice. This statement must be given also in the text.
<Guidelines for animal experiments> Authors should follow the guidelines for the care and use of laboratory animals. In the case of research involving recombinant DNA, experiments should be performed according to the guidelines issued by the authorized agency in the country in which the research was carried out. This statement should be given in the text.

Each author who is listed on the title page should declare any financial support or relationships that may pose conflict of interest. The corresponding author is required to confirm whether all authors have any conflicts of interest to declare, and to send the Conflict of Interest Disclosure Form (available at http://mc.manuscriptcentral.com/ai-jsa) from each author to the Editorial Office at +81-(0)3-5807-1702. Manuscripts cannot be processed until Conflict of Interest Disclosure Forms from all authors have been received. Such statement should also be disclosed in Acknowledgement in the text.

Papers accepted for publication become copyright of Japanese Society of Allergology and all authors will be asked to sign a transfer of copyright form. In signing the transfer of copyright it is assumed that authors have obtained permission to use any copyrighted or previously published material. All authors must read, agree to the conditions outlined in the Copyright Transfer Form and must sign the Form. Articles cannot be published until a signed Copyright Transfer Form has been received. Published articles may not be published elsewhere, in English or any other language, without the permission of the Editor-in-Chief.

Please write your text in good English. Authors may be requested to have the English of the manuscript checked and improved by language editing and copyediting services before submission. Reviewers are not expected to correct grammatical errors and any deficiency in this area may detract from the scientific content of the paper.

Submissions should be doubled-spaced on A4 page. The top, bottom and side margins should be 30 mm. All pages should be numbered consecutively in the top right-hand corner, beginning with the title page. Indent new paragraphs. Turn the hyphenation option off, including only those hyphens that are essential to the meaning. MS Word is preferred format for an electronic file of the manuscript that can be submitted via the Manuscript Central system at http://mc.manuscriptcentral.com/ai-jsa.

Manuscripts should follow the style of the Vancouver agreement detailed in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as presented in JAMA 1997; 277: 927-34.
All measurements must be given in SI units as outlined in the latest edition of Units, Symbols and Abbreviations: A Guide for Medical and Scientific Editors and Authors (Royal Society of Medicine Press, London). Abbreviations should be used sparingly and only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation.
Upon its first use in the title, abstract and text, the common name of a species should be followed by the scientific name (genus, species and authority) in parentheses. However, for well-known species, the scientific name may be omitted from the article title. If no common name exists in English, the scientific name should be used only. At the first mention of a chemical substance, give the generic name only. Trade names should not be used.
Allergen nomenclature should be referred to the list of allergens (http://www.allergen.org/) by International Union of Immunological Societies Allergen Nomenclature Sub-Committee.

For Original Articles the manuscript should be presented in the following order: title page; abstract and key words; introduction; methods; results; discussion; acknowledgements; references; figure legends; tables (each table complete with title and footnotes) and figures. For Case Reports the main text should be presented as follows: introduction; clinical summary; pathological findings and discussion. In all cases each section should start on a new page.
Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page: The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and e-mail address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript, proofs and requests for offprints should be sent.
In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author's contribution to the paper is to be quantified.
The title should be short, informative and contain the major key words. A short running title (less than 40 characters, including spaces) should also be provided.
Abstract and key words: Articles must have a structured abstract that states in 250 words or less the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Background, Methods, Results, and Conclusions. For Case Reports the abstracts should be structured with the headings: Background, Case Summary, and Discussion. The abstract should not contain references.
Five key words should be supplied in alphabetical order below the abstract and should be taken from those recommended by the Index Medicus Medical Subject Headings (MeSH) browser list (http://www.nlm.nih.gov/mesh/meshhome.html).
Text: Authors should use subheadings to divide the sections of their manuscript: Introduction, Methods, Results, Discussion, Acknowledgements, and References.
Introduction: This section should include sufficient background information to set the work in context. The aims of the manuscript should be clearly stated. The introduction should not contain either findings or conclusions.
Methods: This should be concise but provide sufficient detail to allow the work to be repeated by others. The source of material should be given in detail, where possible. Ethical considerations should be detailed.
Results: Results should be presented in a logical sequence in the text, tables and figures; repetitive presentation of the same data in different forms should be avoided. The results should not contain material appropriate to the discussion.
Discussion: This should consider the results in relation to any hypotheses advanced in the introduction and place the study in the context of other work.
Acknowledgments: The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors' industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not allowed.
References: The Vancouver system of referencing should be used. In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited only in tables or figure legends, number them according to the first identification of the table or figure in the text.
In the reference list, the references should be numbered and listed in order of appearance in the text. Cite the names of all authors when there are six or less; when there are seven or more, list the first three authors followed by et al. Names of journals should be abbreviated in the style used in Index Medicus. Reference to unpublished data and personal communications should appear in the text only.
References should be listed in the following form:
Journal articles
l.Colon AR, Ledesma BS, Pardo V, Sandberg DH. Viral potentiation of chemical toxins in the experimental syndrome of hypoglycemia, encephalopathy, and visceral fatty degeneration. Am J Dig Dis 1974; 19: 1091-104.
Non-English journal articles
2.Wakabayashi K, Kakita A, Takahashi H, Obata K, Ikuta F.[Immunohistochemical study of synaptic vesicle-specific protein in Jakob-Creutzfeld disease brain]. Shinkei Kenkyu no Shimpo [Adv Neurol Sci] 1992; 36: 503-10 (in Japanese).
Books
3.Antia FP. Clinical Dietetics and Nutrition, 2nd edn. London: Oxford University Press, 1973.
Chapters in books
4.Weinstein L, Swartz MN. Pathogenic properties of invading micro-organisms. In: Sodeman WA Jr, Sodeman WA (eds). Pathologic Physiology: Mechanisms of Disease. Philadelphia: WB Saunders, 1974; 457-72.
Tables: Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be numbered consecutively in Arabic numerals. Each table should be presented on a separate file with a comprehensive but concise legend above the table. Tables should be double-spaced and vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations should be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. The table and its legend/footnotes should be understandable without reference to the text.
Figures: All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text and can be submitted via Manuscript Central (MC) system at http://mc.manuscriptcentral.com/ai-jsa. Figures should be sized to fit within the column (81 mm) or the full text width (171 mm). Each figure should be presented on a separate file.
Line figures should be supplied using Microsoft PowerPoint or painting software, such as Adobe Photoshop, by saving as high resolution (at least 1200 d.p.i.) EPS (Encapsulated PostScript), TIFF (Tagged-Image File Format), or JPEG format.
Photographs should be supplied using Microsoft PowerPoint or painting software, such as Adobe Photoshop, by saving as high resolution (at least 300 d.p.i.) EPS, TIFF, or JPEG format. Photographs need to be cropped sufficiently to prevent the subject being recognized, or an eye bar used; otherwise, written permission to publish must be obtained. Magnifications should be indicated using a scale bar on the illustration.
Color figures should be supplied using Microsoft PowerPoint or painting software, such as Adobe Photoshop, by saving as high resolution (at least 300 d.p.i.) EPS, TIFF, or JPEG format.
Figure legends should be self-explanatory and typed on a separate sheet. The legend should incorporate definitions of any symbols used and all abbreviations and units of measurement should be explained so that the figure and its legend are understandable without reference to the text. (Provide a letter stating copyright authorization if figures have been reproduced from another source.)
The MC system requires that the combined size of all uploaded files should not exceed 30MB. If your files exceed this limitation, you may contact the Editorial Office by e-mail at <info@jsaweb.jp>.

Brief letters concerning recent publications in the Journal and other subjects of particular interest are reviewed in the Editorial Office. They should be fewer than 500 words, including any brief tabular data, have up to three references, start with the phrase 'To the Editor,' and have a short title. If the letter is accepted, a response from the authors of the Journal article referred to in the letter will be requested when appropriate.

Hypothesis implies speculation. These papers should not be reviews and must not contain new data. Ideally, a hypothesis article is short and outlines a significant jump in thinking that is testable-but not so easily testable that readers will wonder why you have not already done it. Sharing a new idea takes courage. Conciseness too; if you cannot express your line of thought in 1500 words it is probably not a hypothesis.

Page charges: There are no page charges for articles.
Proofs: Proofs will be sent via post or e-mail and should be returned by the specified date. Alterations to the text and figures (other than the essential correction of errors) are unacceptable at proof stage.
Offprints: Authors may order offprints on the appropriate form sent with the page proofs. An Offprint Order Form outlining the cost of offprints will be sent to the corresponding author with the page proofs. Offprints will be provided only if a completed Offprint Order Form is returned to the Japanese Society of Allergology's office by the specified date.
Color figures: The cost of the color figures will be charged to the author except Review Article (Invited).